Multiple Myeloma Coverage from Every Angle

Prashant Kapoor, MD, and Shaji Kumar, MD, on Long-Term Follow-up of Strategies for Upfront Treatment of Multiple Myeloma

Posted: Tuesday, August 11, 2020

Prashant Kapoor, MD, and Shaji Kumar, MD, both of the Mayo Clinic, discuss data from the STaMINA study, which suggest a progression-free survival benefit with tandem autologous hematopoietic cell transplantation in patients with high-risk multiple myeloma.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.